The US Food and Drug Administration is removing health warnings from hormone-based menopause drugs.

The U.S. Food and Drug Administration (FDA) is removing warnings about stroke, heart attack, dementia and other serious risks on hormone-based drugs used to relieve menopause symptoms.

In a written statement, the FDA announced that it has decided to remove warnings on the boxes of medications containing estrogen and progesterone hormones and used to treat symptoms experienced by women during menopause, such as hot flashes.

FDA Commissioner Marty Makary emphasized in a statement that the warnings in question were "outdated" and "unnecessary."

Warnings say it can lead to stroke, heart attack, dementia and other serious risks.

It is stated that removing the warning may encourage more women to take the medication.

Recently, experts and studies have indicated that these hormones may have a positive impact on women's health, but that people are hesitant to take these medications because of the warnings, and have called on the FDA to "remove the warnings."